Publications (original articles or review articles) published in 2014 from OUS - National Advisory Unit on Late Effects after Cancer Treatment
34 publications found
High dose chemotherapy with autologous stem cell transplant for patients with transformed B-cell non-Hodgkin lymphoma in the rituximab era
Leuk Lymphoma, 55 (10), 2319-27
DOI 10.3109/10428194.2013.871632, PubMed 24432894
Left ventricular function in long-term survivors of childhood lymphoma
Am J Cardiol, 114 (3), 483-90
DOI 10.1016/j.amjcard.2014.04.055, PubMed 24948492
Influence of radical prostatectomy for prostate cancer on work status and working life 3 years after surgery
J Cancer Surviv, 9 (2), 172-9
DOI 10.1007/s11764-014-0399-6, PubMed 25216609
Pancreatic cancer risk after treatment of Hodgkin lymphoma
Ann Oncol, 25 (10), 2073-2079
DOI 10.1093/annonc/mdu287, PubMed 25185241
Pelvic irradiation does not increase the risk of hip replacement in patients with gynecological cancer. A cohort study based on 8,507 patients
Acta Orthop, 85 (6), 652-6
DOI 10.3109/17453674.2014.963784, PubMed 25238432
Optimal management of metastatic castration-resistant prostate cancer: highlights from a European Expert Consensus Panel
Eur J Cancer, 50 (9), 1617-27
DOI 10.1016/j.ejca.2014.03.010, PubMed 24703899
Circulating tumor cells in patients with metastatic castration resistant prostate cancer: exploratory findings at a tertiary referral hospital
Res Rep Urol, 6, 121-6
DOI 10.2147/RRU.S68477, PubMed 25328865
Childhood and persistent ADHD symptoms associated with educational failure and long-term occupational disability in adult ADHD
Atten Defic Hyperact Disord, 6 (2), 87-99
DOI 10.1007/s12402-014-0126-1, PubMed 24497125
Effectiveness of one-year pharmacological treatment of adult attention-deficit/hyperactivity disorder (ADHD): an open-label prospective study of time in treatment, dose, side-effects and comorbidity
Eur Neuropsychopharmacol, 24 (12), 1873-84
DOI 10.1016/j.euroneuro.2014.09.013, PubMed 25453480
qPET - a quantitative extension of the Deauville scale to assess response in interim FDG-PET scans in lymphoma
Eur J Nucl Med Mol Imaging, 41 (7), 1301-8
DOI 10.1007/s00259-014-2715-9, PubMed 24604592
A controlled cohort study of long-term income in colorectal cancer patients
Support Care Cancer, 22 (10), 2821-30
DOI 10.1007/s00520-014-2258-4, PubMed 24821364
Increased stomach cancer risk following radiotherapy for testicular cancer
Br J Cancer, 112 (1), 44-51
DOI 10.1038/bjc.2014.552, PubMed 25349972
Safety of cabazitaxel in senior adults with metastatic castration-resistant prostate cancer: results of the European compassionate-use programme
Eur J Cancer, 50 (6), 1090-9
DOI 10.1016/j.ejca.2014.01.006, PubMed 24485664
How should continence and incontinence after radical prostatectomy be evaluated? A prospective study of patient ratings and changes with time
J Urol, 192 (4), 1155-61
DOI 10.1016/j.juro.2014.03.113, PubMed 24727062
Severe postprostatectomy incontinence: Is there an association between preoperative urodynamic findings and outcome of incontinence surgery?
Scand J Urol, 49 (3), 250-9
DOI 10.3109/21681805.2014.980845, PubMed 25428752
How are patient populations characterized in studies investigating depression in advanced cancer? Results from a systematic literature review
J Pain Symptom Manage, 48 (4), 678-98
DOI 10.1016/j.jpainsymman.2013.11.013, PubMed 24681108
Does a parental history of cancer moderate the associations between impaired health status in parents and psychosocial problems in teenagers: a HUNT study
Cancer Med, 3 (4), 919-26
DOI 10.1002/cam4.245, PubMed 24723456
Arm and shoulder morbidity following surgery and radiotherapy for breast cancer
Acta Oncol, 53 (4), 521-9
DOI 10.3109/0284186X.2014.880512, PubMed 24495044
Cancer survivorship in adults
Recent Results Cancer Res, 197, 103-20
DOI 10.1007/978-3-642-40187-9_8, PubMed 24305772
Fatigue in male lymphoma survivors differs between diagnostic groups and is associated with latent hypothyroidism
Acta Oncol, 54 (1), 49-59
DOI 10.3109/0284186X.2014.948057, PubMed 25140862
Depression in advanced cancer--assessment challenges and associations with disease load
J Affect Disord, 173, 176-84
DOI 10.1016/j.jad.2014.11.006, PubMed 25462414
Adding intensity-modulated radiotherapy to the pelvis does not worsen the adverse effect profiles compared to limited field radiotherapy in men with prostate cancer at 12-month follow-up
Acta Oncol, 53 (10), 1380-9
DOI 10.3109/0284186X.2014.916042, PubMed 24844918
Early outcome of orchiopexy and analysis of predictive factors: a retrospective study from 2001 to 2010 in a Norwegian regional hospital
Scand J Urol, 48 (5), 474-81
DOI 10.3109/21681805.2014.905631, PubMed 24720831
Changes in prostate-specific antigen, markers of bone metabolism and bone scans after treatment with radium-223
Scand J Urol, 49 (3), 211-7
DOI 10.3109/21681805.2014.982169, PubMed 25515952
Personalizing, not patronizing: the case for patient autonomy by unbiased presentation of management options in stage I testicular cancer
Ann Oncol, 26 (5), 833-838
DOI 10.1093/annonc/mdu514, PubMed 25378299
Successful change of treatment strategy in elderly patients with primary central nervous system lymphoma by de-escalating induction and introducing temozolomide maintenance: results from a phase II study by the Nordic Lymphoma Group
Haematologica, 100 (4), 534-40
DOI 10.3324/haematol.2014.108472, PubMed 25480497
Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blind, randomised trial
Lancet Oncol, 15 (7), 738-46
DOI 10.1016/S1470-2045(14)70183-4, PubMed 24836273
Sexual dysfunction and infertility as late effects of cancer treatment
EJC Suppl, 12 (1), 41-53
DOI 10.1016/j.ejcsup.2014.03.004, PubMed 26217165
Prognostic factors in malignant ovarian germ cell tumours (The Surveillance, Epidemiology and End Results experience 1978-2010)
Eur J Cancer, 50 (11), 1942-50
DOI 10.1016/j.ejca.2014.03.288, PubMed 24857045
Fertility and gonadal function after adjuvant therapy in women diagnosed with a malignant ovarian germ cell tumor (MOGCT) during the "cisplatin era"
Gynecol Oncol, 136 (2), 224-9
DOI 10.1016/j.ygyno.2014.12.010, PubMed 25511159
Longitudinal serum testosterone, luteinizing hormone, and follicle-stimulating hormone levels in a population-based sample of long-term testicular cancer survivors
J Clin Oncol, 32 (6), 571-8
DOI 10.1200/JCO.2013.51.2715, PubMed 24419125
Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3-pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial
Lancet Oncol, 16 (1), 76-86
DOI 10.1016/S1470-2045(14)71160-X, PubMed 25498218
Localized prostate cancer in Norway, the United States, and Spain: between-country differences of variables before treatment among patients eligible for curative treatment
Clin Genitourin Cancer, 12 (4), e117-25
DOI 10.1016/j.clgc.2013.12.007, PubMed 24524968
Siltuximab for multicentric Castleman's disease: a randomised, double-blind, placebo-controlled trial
Lancet Oncol, 15 (9), 966-74
DOI 10.1016/S1470-2045(14)70319-5, PubMed 25042199